Finance

Lists
A:NYSE
Agilent Technologies Inc
USD 139,13
+0,32%
(+0,44) 1D
31 Jul., 15:11:55 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for A...
Open
USD 138,47
High
USD 139,30
Low
USD 135,78
Mkt. cap
39,29 mjd
Avg. vol.
2,33 m
Volume
826,10 k
Dividend
0,73%
Quarterly dividend
USD 0,25
Ex-dividend date
30 Jun. 2026
P/E ratio
27,97
52-wk high
USD 160,27
52-wk low
USD 108,35
EPS
USD 4,97
Beta
1,25
Shares outstanding
282,43 m
No. of employees
18 k
Open
USD 138,47
High
USD 139,30
Low
USD 135,78
Mkt. cap
39,29 mjd
Avg. vol.
2,33 m
Volume
826,10 k
Dividend
0,73%
Quarterly dividend
USD 0,25
Ex-dividend date
30 Jun. 2026
P/E ratio
27,97
52-wk high
USD 160,27
52-wk low
USD 108,35
EPS
USD 4,97
Beta
1,25
Shares outstanding
282,43 m
No. of employees
18 k
News stories
From sources across the web
Profile
Agilent Technologies, Inc. is an American global company headquartered in Santa Clara, California, that provides instruments, software, services, and consumables for laboratories. Agilent was established in 1999 as a spin-off from Hewlett-Packard. The resulting initial public offering of Agilent stock was the largest in the history of Silicon Valley at the time. From 1999 to 2014, the company produced optics, semiconductors, EDA software and test and measurement equipment for electronics; that division was spun off to form Keysight. Since then, the company has continued to expand into pharmaceutical, diagnostics & clinical, and academia & government markets. Wikipedia
About Agilent Technologies Inc
CEOPadraig McDonnell
Employees18 k
Founded1999
HeadquartersSanta Clara, Kalifornië, Verenigde State van Amerika
SectorHealth care
Websiteagilent.com
Analyst ratings
Based on 16 analysts giving stock ratings to A in the past 3 months
Strong buy
Buy
13
Hold
3
Sell
0
12-month forecast
Based on 16 Wall Street analysts offering 12 month price targets for A in the last 3 months.
Highest
Current USD 139,13
USD 180,00 (+29,38%)
Average
USD 155,13 (+11,50%)
Lowest
USD 135,00 (-2,97%)
Analyst
Recommendation
Action
Price target
Projected
Date
Eve Burstein
Bernstein
Buy
Maintained
USD 155,00
+11,4%
07/22/2026
Tycho Peterson
Jefferies
Hold
Initiated
USD 135,00
-3%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
USD 148,00
+6,4%
07/06/2026
Blayne Curtis
Jefferies
Buy
Maintained
USD 550,00
+295,3%
06/30/2026
Luke Sergott
Barclays
Buy
Reiterated
USD 150,00
+7,8%
06/24/2026
David Westenberg
Piper Sandler
Hold
Initiated
USD 150,00
+7,8%
06/11/2026
Sidharth Sahoo
HSBC
Buy
Maintained
USD 165,00
+18,6%
06/03/2026
Michael Ryskin
Bank of America Securities
Buy
Reiterated
USD 155,00
+11,4%
06/02/2026
Michael Polark
Wolfe Research
Hold
Initiated
USD 135,00
-3%
06/01/2026
Daniel Arias
Stifel Nicolaus
Buy
Maintained
USD 170,00
+22,2%
05/28/2026
Casey Woodring
J.P. Morgan
Buy
Maintained
USD 180,00
+29,4%
05/27/2026
Evie Koslosky
Goldman Sachs
Buy
Maintained
USD 155,00
+11,4%
05/27/2026
Kallum Titchmarsh
Morgan Stanley
Buy
Reiterated
USD 160,00
+15%
05/28/2026
Brandon Couillard
Wells Fargo
Buy
Maintained
USD 160,00
+15%
05/28/2026
Daniel Brennan
TD Cowen
Buy
Reiterated
USD 155,00
+11,4%
05/27/2026
Dan Leonard
RBC Capital
Buy
Maintained
USD 153,00
+10%
05/26/2026
Catherine Ramsey Schulte
Robert W. Baird
Buy
Maintained
USD 156,00
+12,1%
05/26/2026
Jack Meehan
Nephron
Buy
Upgraded
USD 145,00
+4,2%
03/26/2026
Patrick B Donnelly
Citi
Buy
Maintained
USD 185,00
+33%
03/11/2026
Last report
27 Mei 2026
Fiscal period
Q2 2026
EPS / Est. (USD)
USD 1,49 / USD 1,41
+5,80%beat
Revenue / Est. (USD)
1,84 mjd / 1,80 mjd
+2,03%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jul. 2025
Okt. 2025
Jan. 2026
Apr. 2026
Revenue
1,74 mjd
1,86 mjd
1,80 mjd
1,84 mjd
Cost of goods sold
850,00 m
871,00 m
847,00 m
842,00 m
Cost of revenue
850,00 m
871,00 m
847,00 m
842,00 m
Research and development expenses
111,00 m
117,00 m
117,00 m
126,00 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
374,00 m
368,00 m
423,00 m
432,00 m
Operating expense
485,00 m
485,00 m
540,00 m
558,00 m
Total operating expenses
1,34 mjd
1,36 mjd
1,39 mjd
1,40 mjd
Operating income
403,00 m
505,00 m
411,00 m
435,00 m
Other non operating income
4,00 m
31,00 m
3,00 m
9,00 m
EBT including unusual items
366,00 m
442,00 m
364,00 m
408,00 m
EBT excluding unusual items
395,00 m
514,00 m
404,00 m
429,00 m
Income tax expense
30,00 m
8,00 m
59,00 m
69,00 m
Effective tax rate
8,20%
1,81%
16,21%
16,91%
Other operating expenses
-
-
-
-
Net income
336,00 m
434,00 m
305,00 m
339,00 m
Net profit margin
19,33%
23,32%
16,96%
18,47%
Earnings per share
1,37
1,59
1,36
1,49
Interest and investment income
16,00 m
17,00 m
15,00 m
13,00 m
Interest expense
-28,00 m
-27,00 m
-25,00 m
-25,00 m
Net interest expenses
-12,00 m
-10,00 m
-10,00 m
-12,00 m
Depreciation and amortization charges
-
-
-
-
EBITDA
475,00 m
576,00 m
478,00 m
502,00 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme